Adaptive Biotechnologies ...

NASDAQ: ADPT · Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.04
0.08%
After-hours: Aug 15, 2025, 04:54 PM EDT

Adaptive Biotechnologies Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
178.96M 170.28M 185.31M 154.34M
Cost of Revenue
72.08M 75.55M 57.91M 49.3M
Gross Profit
106.88M 94.72M 127.4M 105.04M
Operating Income
-162.55M -227.03M -200.19M -208.97M
Interest Income
14.53M 15.53M 4.06M 1.67M
Pretax Income
-159.59M -225.3M -200.37M -207.3M
Net Income
-159.49M -225.25M -142.46M -205.61M
Selling & General & Admin
157.56M 172.51M 184.13M 169.97M
Research & Development
102.95M 122.12M 141.76M 142.34M
Other Expenses
8.91M 27.13M 1.7M 1.7M
Operating Expenses
269.43M 321.76M 327.58M 314.01M
Interest Expense
11.58M 13.8M 4.24M n/a
Selling & Marketing Expenses
84.76M 88.58M 95.6M 95.47M
Cost & Expenses
341.51M 397.31M 385.49M 363.31M
Income Tax Expense
n/a n/a -57.9M -1.69M
Shares Outstanding (Basic)
147.1M 144.38M 142.52M 140.35M
Shares Outstanding (Diluted)
147.1M 144.38M 142.52M 140.35M
EPS (Basic)
-1.08 -1.56 -1 -1.46
EPS (Diluted)
-1.08 -1.56 -1 -1.46
EBITDA
-128.76M -189.27M -167.98M -193.34M
EBIT
-148.01M -211.5M -196.13M -207.3M
Depreciation & Amortization
19.26M 22.23M 28.15M 20.98M